Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
US7807793B2 · kind B2 · utility
0Cited by
6References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 26, 2006 |
| Grant date | Oct 5, 2010 |
| Priority date | — |
| Expiry date | Jul 26, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Chimeric and humanized IL4 MAbs derived from affinity MAbs, pharmaceutical compositions containing same, and methods of treatment are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.